EPO clarifies application of ‘computer program’ patentability exception to claims relating to computer simulations

http://www.twobirds.com/en/patenthub/shared/articles/2021/global/epo-clarifies-application-of-computer-program-patentability

Chris de Mauny considers the EPO’s Enlarged Board of Appeal decision in G 1/19 (SIMULATIONS). The Board implicitly endorsed the existing COMVIK approach for computer-implemented inventions and made clear that the same approach applies to simulations, ...

12 March 2021

Patent claims directed at solving the volume of workplace health & safety paperwork are ‘a good idea’ but unpatentable: Federal Court of Australia

http://www.twobirds.com/en/patenthub/shared/articles/2021/australia/patent-claims-directed-at-solving-the-volume-of-workplace-health-and-safety-paperwork

Can a patentee overcome a decision that the invention claimed is not a manner of manufacture (ie. does not contain patentable subject matter) by amendment? On 29 January 2021, the decision in Repipe #2 was handed down which considers this issue.

23 February 2021

Federal Court confirms that schemes are not patentable merely because they are "new and ingenious" and are implemented using a computer

http://www.twobirds.com/en/patenthub/shared/articles/2020/australia/full-federal-court-confirms-that-schemes-are-not-patentable-merely-because-they-are-new

The Federal Court of Australia has found a patent directed at a digital marketing scheme no more than a list of steps to be implemented by a computer using its well-known functions, and is not a patentable invention: Commissioner of Patents v Rokt Pte Ltd ...

22 May 2020

Full Federal Court Confirms an Application to list on the PBS Prior to Patent Expiry is a non infringing Act

http://www.twobirds.com/en/patenthub/shared/articles/2017/australia/full-federal-court-confirms-an-application-to-list-on-the-pbs-prior-to-patent-expiry

Late last week, the Full Federal Court of Australia confirmed that the mere act of filing a Pharmaceutical Benefits Scheme (PBS) application for a generic pharmaceutical product is not, of itself, an act of infringement provided that the generic product will ...

19 April 2017